Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2025-12-25 @ 10:42 PM
Study NCT ID:
NCT00705367
Status:
COMPLETED
Last Update Posted:
2013-07-30
First Post:
2008-06-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2009-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-24
First Submit QC Date:
None
Study First Post Date:
2008-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-05-04
Results First Submit QC Date:
None
Results First Post Date:
2010-06-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-23
Last Update Post Date:
2013-07-30
Last Update Post Date Type:
ESTIMATED